Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
10.31
+0.07 (0.68%)
At close: Dec 20, 2024, 4:00 PM
10.27
-0.04 (-0.39%)
After-hours: Dec 20, 2024, 7:32 PM EST
Omeros Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
198
Market Cap
597.46M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cross Country Healthcare | 1.45B |
Varex Imaging | 811.00M |
GRAIL | 117.67M |
Capricor Therapeutics | 23.23M |
Stoke Therapeutics | 16.74M |
Autolus Therapeutics | 10.09M |
Arbutus Biopharma | 6.74M |
Altimmune | 52.00K |
OMER News
- 2 days ago - Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges - Benzinga
- 2 days ago - Omeros' Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA - Business Wire
- 11 days ago - Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting - Business Wire
- 19 days ago - Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting - Business Wire
- 4 weeks ago - Omeros Corporation Provides Update on Progress Toward BLA Resubmission - Business Wire
- 5 weeks ago - Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Omeros Corporation Reports Third Quarter 2024 Financial Results - Business Wire
- 5 weeks ago - Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024 - Business Wire